Mitobridge

Mitobridge is discovering and developing novel therapeutics that improve mitochondrial functions. Building upon the emerging scientific findings linking mitochondrial dysfunction with disease pathologies, we are progressing innovative approaches to the treatment of diseases with high unmet medical need. Our strategy is to establish proof of concept in rare diseases and then expand into more common diseases. Mitobridge has assembled a strong team with expertise in advancing ground-breaking therapeutics into the clinic. Our scientific founders and advisors include leaders in mitochondrial biology, metabolism and aging with experience in translating novel discoveries into next-generation medicines. We are also using this biology based approach to explore other important pathways with high potential for clinical impact.